These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 29025958
1. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression. Chakravarthi BVSK, Chandrashekar DS, Agarwal S, Balasubramanya SAH, Pathi SS, Goswami MT, Jing X, Wang R, Mehra R, Asangani IA, Chinnaiyan AM, Manne U, Sonpavde G, Netto GJ, Gordetsky J, Varambally S. Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958 [Abstract] [Full Text] [Related]
2. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis. Vetter NS, Kolb EA, Mills CC, Sampson VB. Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089 [Abstract] [Full Text] [Related]
3. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1. Zhu L, Chen Y, Nie K, Xiao Y, Yu H. Cancer Biomark; 2018 Jul; 23(2):301-309. PubMed ID: 30198871 [Abstract] [Full Text] [Related]
4. Stathmin 1 is a potential novel oncogene in melanoma. Chen J, Abi-Daoud M, Wang A, Yang X, Zhang X, Feilotter HE, Tron VA. Oncogene; 2013 Mar 07; 32(10):1330-7. PubMed ID: 22665054 [Abstract] [Full Text] [Related]
5. MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer. Chakravarthi BV, Goswami MT, Pathi SS, Robinson AD, Cieślik M, Chandrashekar DS, Agarwal S, Siddiqui J, Daignault S, Carskadon SL, Jing X, Chinnaiyan AM, Kunju LP, Palanisamy N, Varambally S. Oncogene; 2016 Dec 08; 35(49):6330-6340. PubMed ID: 27270442 [Abstract] [Full Text] [Related]
6. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1. Wang X, Peng L, Gong X, Zhang X, Sun R, Du J. Cell Physiol Biochem; 2018 Dec 08; 50(6):2249-2259. PubMed ID: 30423576 [Abstract] [Full Text] [Related]
7. Role of transcriptional corepressor CtBP1 in prostate cancer progression. Wang R, Asangani IA, Chakravarthi BV, Ateeq B, Lonigro RJ, Cao Q, Mani RS, Camacho DF, McGregor N, Schumann TE, Jing X, Menawat R, Tomlins SA, Zheng H, Otte AP, Mehra R, Siddiqui J, Dhanasekaran SM, Nyati MK, Pienta KJ, Palanisamy N, Kunju LP, Rubin MA, Chinnaiyan AM, Varambally S. Neoplasia; 2012 Oct 08; 14(10):905-14. PubMed ID: 23097625 [Abstract] [Full Text] [Related]
8. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells. Zhu M, Zheng Z, Huang J, Ma X, Huang C, Wu R, Li X, Liang Z, Deng F, Wu J, Geng S, Xie C, Zhong C. J Cell Biochem; 2019 Sep 08; 120(9):15616-15624. PubMed ID: 31042325 [Abstract] [Full Text] [Related]
9. JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance. Cai X, Duan X, Tang T, Cui S, Wu T. BMC Cancer; 2023 May 10; 23(1):423. PubMed ID: 37165308 [Abstract] [Full Text] [Related]
10. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Lu W, Hu Y, Ma Q, Zhou L, Jiang L, Li Z, Zhao S, Xu Y, Shi W, Li S, Liu Y. Oncotarget; 2016 Sep 20; 7(38):62364-62376. PubMed ID: 27577078 [Abstract] [Full Text] [Related]
11. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a. Liang J, Li Y, Daniels G, Sfanos K, De Marzo A, Wei J, Li X, Chen W, Wang J, Zhong X, Melamed J, Zhao J, Lee P. Mol Cancer Res; 2015 Apr 20; 13(4):681-8. PubMed ID: 25587085 [Abstract] [Full Text] [Related]
15. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis. Liu X, Luo X, Wu Y, Xia D, Chen W, Fang Z, Deng J, Hao Y, Yang X, Zhang T, Zhou L, Wu Y, Wang Q, Xu J, Hu X, Li L. Cell Physiol Biochem; 2018 Apr 20; 50(1):261-276. PubMed ID: 30282072 [Abstract] [Full Text] [Related]